These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27371725)

  • 21. H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.
    Infantes S; Samino Y; Lorente E; Jiménez M; García R; Del Val M; López D
    J Immunol; 2010 Apr; 184(7):3351-5. PubMed ID: 20200278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carboxypeptidase ACE shapes the MHC class I peptide repertoire.
    Shen XZ; Billet S; Lin C; Okwan-Duodu D; Chen X; Lukacher AE; Bernstein KE
    Nat Immunol; 2011 Oct; 12(11):1078-85. PubMed ID: 21964607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.
    Blanchard N; Gonzalez F; Schaeffer M; Joncker NT; Cheng T; Shastri AJ; Robey EA; Shastri N
    Nat Immunol; 2008 Aug; 9(8):937-44. PubMed ID: 18587399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of nonclassical MHC antigen presentation.
    Hansen TH; Huang S; Arnold PL; Fremont DH
    Nat Immunol; 2007 Jun; 8(6):563-8. PubMed ID: 17514210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.
    Serwold T; Gaw S; Shastri N
    Nat Immunol; 2001 Jul; 2(7):644-51. PubMed ID: 11429550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.
    Saric T; Chang SC; Hattori A; York IA; Markant S; Rock KL; Tsujimoto M; Goldberg AL
    Nat Immunol; 2002 Dec; 3(12):1169-76. PubMed ID: 12436109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present Yourself! By MHC Class I and MHC Class II Molecules.
    Rock KL; Reits E; Neefjes J
    Trends Immunol; 2016 Nov; 37(11):724-737. PubMed ID: 27614798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nilabh Shastri - Towards understanding classical and non-classical MHC-I antigen processing and presentation.
    Kessler BM
    Cell Immunol; 2022 Dec; 382():104638. PubMed ID: 36371991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limit of T cell tolerance to self proteins by peptide presentation.
    Schild H; Rötzschke O; Kalbacher H; Rammensee HG
    Science; 1990 Mar; 247(4950):1587-9. PubMed ID: 2321019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional expression and recognition of nonclassical MHC class I T10b is not peptide-dependent.
    Kaliyaperumal A; Falchetto R; Cox A; Dick R; Shabanowitz J; Chien YH; Matis L; Hunt DF; Bluestone JA
    J Immunol; 1995 Sep; 155(5):2379-86. PubMed ID: 7650372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The final touches make perfect the peptide-MHC class I repertoire.
    Hammer GE; Kanaseki T; Shastri N
    Immunity; 2007 Apr; 26(4):397-406. PubMed ID: 17459809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway.
    Snyder HL; Bacík I; Yewdell JW; Behrens TW; Bennink JR
    Eur J Immunol; 1998 Apr; 28(4):1339-46. PubMed ID: 9565374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Composition of the HLA-DR-associated human thymus peptidome.
    Collado JA; Alvarez I; Ciudad MT; Espinosa G; Canals F; Pujol-Borrell R; Carrascal M; Abian J; Jaraquemada D
    Eur J Immunol; 2013 Sep; 43(9):2273-82. PubMed ID: 23719902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on "Characterizing the N-terminal processing motif of MHC class I ligands".
    Colaco CA
    J Immunol; 2008 Sep; 181(6):3731; author reply 3731-2. PubMed ID: 18768822
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.
    Brophy SE; Jones LL; Holler PD; Kranz DM
    Mol Immunol; 2007 Mar; 44(9):2184-94. PubMed ID: 17169430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
    Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
    Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERAAP prevents leader dominance?
    Colaco CA
    Immunol Cell Biol; 2008 Oct; 86(7):548. PubMed ID: 18725884
    [No Abstract]   [Full Text] [Related]  

  • 40. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.